Brentuximab vedotin

Nat Rev Drug Discov. 2012 Jan 3;11(1):19-20. doi: 10.1038/nrd3629.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Brentuximab Vedotin
  • Clinical Trials, Phase I as Topic / trends
  • Hodgkin Disease / drug therapy
  • Humans
  • Immunoconjugates / therapeutic use*
  • Ki-1 Antigen / immunology*
  • Lymphoma, Large-Cell, Anaplastic / drug therapy

Substances

  • Immunoconjugates
  • Ki-1 Antigen
  • Brentuximab Vedotin